Acorda Multiple Sclerosis Drug Patents Are Invalid, Federal Circuit Affirms
WASHINGTON, D.C. — In a divided Sept. 10 holding, the Federal Circuit U.S. Court of Appeals upheld findings by a Delaware federal judge that four Acorda Therapeutics Inc. patents relating to...To view the full article, register now.
Already a subscriber? Click here to view full article